However, the predictions of a 50% Tecfidera market share in the US I’m seeing from some analysts seem overblown; I doubt that any single MS drug will ever attain such a threshold.
A pill rather than shots (with the reactions) or infusions is compelling.
My wife is having a lot of mild infections that I assume are due to the immunosuppression of Tecfidera.
How amazing are the deeds of the LORD! All who delight in Him should ponder them. Ps 111:2